Egyptian researchers have developed the first validated thin-layer chromatography method to simultaneously measure ...
This Week's Global Pharma News] Roche and Pfizer Receive US FDA Approvals, argenx Discontinues Phase 3 Trial, New Developments in IgG Degraders | Global Pharma Trends MRs Should KnowMonday, October 5 ...
Many sexually transmitted infections can remain undetected for months or years. Learn how testing frequency depends on ...
Bone is never finished. Long after a skeleton reaches its adult size, the tissue continues to dismantle and rebuild itself, ...
Safety and efficacy results of cizutamig, an investigational B-cell maturation antigen x cluster of differentiation 3 (BCMA×CD3) T-cell engager: Interim results from a Phase 1b open-label, ...
Skyrizi (risankizumab) is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for ...
A comprehensive look at the safety data from the MARIPOSA-2 trial, including rates of adverse events, toxicities, and treatment modifications across the three regimens. Specific details are provided ...
For persons living with both type 2 diabetes and obesity, weight management may be the most effective therapy for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) receptor agonists have potent ...
Building muscle in your forties and beyond doesn’t necessarily mean spending more time in the gym. In fact, scaling back your training could be just as effective, particularly if you’re struggling to ...
Sept 29 (Reuters) - Shell (SHEL.L), opens new tab and its partners on Tuesday gave the green light to a LNG Canada Phase 2 expansion in Kitimat, British Columbia, a C$33 billion bet that will double ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results